Maternal obesity, folate intake, and neural tube defects in offspring

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 97, Issue 2, 2013, Pages 115-122

  Mcmahon, Daria M ^a   Liu, Jihong ^a   Zhang, Hongmei ^a   Torres, Myriam E ^a   Best, Robert G ^a,b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE GREENVILLE   (United States)

Author keywords

Folate; Folic acid; Neural tube defects; Obesity; Pregnancy

Indexed keywords

FOLIC ACID; MULTIVITAMIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL OBESITY; NEURAL TUBE DEFECT; OBESITY; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROGENY; RACE; RISK FACTOR; SMOKING; UNDERWEIGHT; VITAMIN INTAKE;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; EDUCATIONAL STATUS; FEMALE; FETUS; FOLIC ACID; HUMANS; INFANT; INFANT, NEWBORN; LIVE BIRTH; LOGISTIC MODELS; MALE; NEURAL TUBE DEFECTS; OBESITY; ODDS RATIO; PREGNANCY; QUESTIONNAIRES; RISK FACTORS; SOUTH CAROLINA; STILLBIRTH; VITAMINS;

EID: 84873723875     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23113     Document Type: Article

References (39)

1. Allen WP, Stevenson RE, Thompson SJ, Dean JH. 1996. The impact of prenatal diagnosis on NTD surveillance. Prenat Diagn 16: 531-535.
2. Anderson JL, Waller DK, Canfield MA, et al. 2005. Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology 16: 87-92.
3. Bower C, Stanley FJ. 1989. Dietary folate as a risk factor for neural tube defects: evidence from a case-control study in Western Australia. Med J Aust 150: 613-619.
4. Centers for Disease Control and Prevention. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 41: 1-7.
5. Collins JS, Atkinson KK, Dean JH, et al. 2011. Long term maintenance of neural tube defects prevention in a high prevalence state. J Pediatr 159: 143-149.e142.
6. Finer LB, Zolna MR. 2011. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 84: 478-485.
7. Food and Drug Administration. 1996. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid, Final Rule. 21 CFR Parts 136, 137, and 139. Fed Reg 61: 8781-8797.
8. Greene ND, Stanier P, Copp AJ. 2009. Genetics of human neural tube defects. Hum Mol Genet 18: R113-R129.
9. Hendricks KA, Nuno OM, Suarez L, Larsen R. 2001. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology 12: 630-635.
10. Honein MA, Paulozzi LJ, Mathews TJ, et al. 2001. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285: 2981-2986.
11. Kallen K. 1998. Maternal smoking, body mass index, and neural tube defects. Am J Epidemiol 147: 1103-1111.
12. Larsen WJ. 1997. Human Embryology. 2nd ed. New York: Churchill Livingstone.
13. Laurence K. 1983. Dietary approaches to the prevention of neural tube defects. Nutr Health 2: 181-189.
14. Mikhail LN, Walker CK, Mittendorf R. 2002. Association between maternal obesity and fetal cardiac malformations in African Americans. J Natl Med Assoc 94: 695-700.
15. Milunsky A, Jick H, Jick SS, et al. 1989. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262: 2847-2852.
16. Moore LL, Bradlee ML, Singer MR, et al. 2003. Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology 14: 200-205.
17. Moore LL, Singer MR, Bradlee ML, et al. 2000. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology 11: 689-694.
18. National Institutes of Health. 2000. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. NIH Publication Number 00-4084. Avalilable at:http://www.nhlbi.nih.gov/guidelines/obesity/prctgd_c.pdf. Accessed September 1, 2012.
19. Olney RS, Mulinare J. 2002. Trends in neural tube defect prevalence, folic acid fortification, and vitamin supplement use. Semin Perinatol 26: 277-285.
20. Park S, Sappenfield WM, Bish C, et al. 2011. Reliability and validity of birth certificate prepregnancy weight and height among women enrolled in prenatal WIC program: Florida, 2005. Matern Child Health J 15: 851-859.
21. Ray JG, Thompson MD, Vermeulen MJ, et al. 2007. Metabolic syndrome features and risk of neural tube defects. BMC Pregnancy Childbirth 7: 21.
22. Ray JG, Wyatt PR, Vermeulen MJ, et al. 2005. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynecol 105: 261-265.
23. Reece EA. 2012. Diabetes-induced birth defects: what do we know? What can we do? Curr Diab Rep 12: 24-32.
24. Reisin E, Alpert MA. 2005. Definition of the metabolic syndrome: current proposals and controversies. Am J Med Sci 330: 269-272.
25. Scott J, Kirke P, Molloy A, et al. 1994. The role of folate in the prevention of neural-tube defects. Proc Nutr Soc 53: 631-636.
26. Shaw GM, Todoroff K, Schaffer DM, Selvin S. 2000. Maternal height and prepregnancy body mass index as risk factors for selected congenital anomalies. Paediatr Perinat Epidemiol 14: 234-239.
27. Shaw GM, Velie EM, Schaffer D. 1996. Risk of neural tube defect-affected pregnancies among obese women. JAMA 275: 1093-1096.
28. Stevenson RE, Allen WP, Pai GS, et al. 2000. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 106: 677-683.
29. Stothard KJ, Tennant PW, Bell R, Rankin J. 2009. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 301: 636-650.
30. Suarez L, Felkner M, Brender JD, et al. 2012. Neural tube defects on the Texas-Mexico border: what we've learned in the 20 years since the Brownsville cluster. Birth Defects Res A Clin Mol Teratol 94: 882-892.
31. Thompson SJ, Torres ME, Stevenson RE, et al. 2003. Periconceptional multivitamin folic acid use, dietary folate, total folate and risk of neural tube defects in South Carolina. Ann Epidemiol 13: 412-418.
32. Waller DK, Mills JL, Simpson JL, et al. 1994. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol 170: 541-548.
33. Waller DK, Shaw GM, Rasmussen SA, et al. 2007. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 161: 745-750.
34. Watkins ML, Rasmussen SA, Honein MA, et al. 2003. Maternal obesity and risk for birth defects. Pediatrics 111: 1152-1158.
35. Watkins ML, Scanlon KS, Mulinare J, Khoury MJ. 1996. Is maternal obesity a risk factor for anencephaly and spina bifida? Epidemiology 7: 507-512.
36. Werler MM, Louik C, Shapiro S, Mitchell AA. 1996. Prepregnant weight in relation to risk of neural tube defects. JAMA 275: 1089-1092.
37. Werler MM, Shapiro S, Mitchell AA. 1993. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 269: 1257-1261.
38. Willett WC, Sampson L, Browne ML, et al. 1988. The use of self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 127: 188-199.
39. Williams LJ, Mai CT, Edmonds LD, et al. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66: 33-39.